Publication:
Prophylactic Treatment of Migraine

Simple item page
dc.contributor.authorGürsoy, AZİZE ESRA
dc.contributor.authorERTAŞ, M
dc.contributor.institutionauthorGÜRSOY, AZIZE ESRA
dc.date.accessioned2020-10-29T13:12:14Z
dc.date.available2020-10-29T13:12:14Z
dc.date.issued2013-08-01T00:00:00Z
dc.description.abstractMigraine is a common chronic neurological disease characterized by episodic attacks of headache and associated symptoms. The pharmacological treatment of migraine may be acute or prophylactic, and patients with frequent, severe headaches often require both approaches. Prophylactic treatment is used to reduce the frequency, duration, or severity of attacks, to enhance the benefits of acute treatments, and to improve patient's ability to function normally. Prophylactic treatment may also prevent progression from episodic migraine to chronic migraine and may result in reductions in health-care cost. The currently available pharmacological options for migraine prophylaxis include a wide array of medications. The major medication groups for prophylactic treatment include beta-blockers, anticonvulsant, drugs such as topiramate and valproate, antidepressant drugs, such as amitriptyline and selective serotonin and selective serotonin-norepinephrine reuptake inhibitors (SNRIs), calcium channel antagonists and neurotoxins. The agent for prophylactic treatment should be chosen based on the efficacy and side-effect profile of the drug, and the patient's coexistent and comorbid conditions.
dc.identifier.citationGürsoy A. E. , ERTAŞ M., -Prophylactic Treatment of Migraine.-, Noro psikiyatri arsivi, cilt.50, 2013
dc.identifier.doi10.4274/npa.y7199
dc.identifier.pubmed28360581
dc.identifier.scopus84883354307
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25118
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353075/
dc.identifier.wosWOS:000323550400006
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMigraine
dc.titleProphylactic Treatment of Migraine
dc.typeArticle
dspace.entity.typePublication
local.avesis.id0c28fd82-7163-47f5-9eb1-e9eb38b94636
local.publication.isinternational1
relation.isAuthorOfPublication0f02f2b2-8a90-4970-83f0-51e951bb5aee
relation.isAuthorOfPublication.latestForDiscovery0f02f2b2-8a90-4970-83f0-51e951bb5aee
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
npa-50-s1-s30.pdf
Size:
2.36 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler